KLHL26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.977200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.717600E-01
Normal-vs-Stage2
9.008400E-01
Normal-vs-Stage3
1.348610E-01
Normal-vs-Stage4
6.376800E-01
Stage1-vs-Stage2
3.746600E-01
Stage1-vs-Stage3
1.234630E-01
Stage1-vs-Stage4
8.110400E-01
Stage2-vs-Stage3
6.456100E-02
Stage2-vs-Stage4
3.867200E-01
Stage3-vs-Stage4
1.152160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.642400E-01
Normal-vs-AfricanAmerican
6.738200E-01
Normal-vs-Asian
8.985800E-01
Caucasian-vs-AfricanAmerican
5.688000E-01
Caucasian-vs-Asian
7.397800E-01
AfricanAmerican-vs-Asian
7.814000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.462600E-01
Normal-vs-Female
9.258800E-01
Male-vs-Female
5.483800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.214200E-01
Normal-vs-Age(41-60Yrs)
7.223400E-01
Normal-vs-Age(61-80Yrs)
8.593400E-01
Normal-vs-Age(81-100Yrs)
7.257800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.067000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.051160E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.087800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.390300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.403000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.223800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.138400E-01
Normal-vs-Daily Drinker
9.733400E-01
Normal-vs-Weekly Drinker
8.479000E-01
Normal-vs-Occasional Drinker
6.752400E-01
Normal-vs-Social Drinker
7.721600E-01
Non Drinker-vs-Daily Drinker
4.967800E-01
Non Drinker-vs-Weekly Drinker
3.088600E-01
Non Drinker-vs-Occasional Drinker
1.381590E-01
Non Drinker-vs-Social Drinker
8.499000E-01
Daily Drinker-vs-Weekly Drinker
6.781600E-01
Daily Drinker-vs-Occasional Drinker
4.598200E-01
Daily Drinker-vs-Social Drinker
6.784200E-01
Weekly Drinker-vs-Occasional Drinker
8.464000E-01
Weekly Drinker-vs-Social Drinker
4.501600E-01
Occasional Drinker-vs-Social Drinker
2.304400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.919410E-01
Normal-vs-Grade 2
1.588080E-02
Normal-vs-Grade 3
2.012200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.947400E-01
Grade 1-vs-Grade 3
9.315600E-01
Grade 1-vs-Grade 4
1.919410E-01
Grade 2-vs-Grade 3
7.304600E-01
Grade 2-vs-Grade 4
1.588080E-02
Grade 3-vs-Grade 4
2.012200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.894200E-01
Normal-vs-NonDiabetic
9.397400E-01
Diabetic-vs-NonDiabetic
7.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.734800E-01
Normal-vs-NoPancreatitis
9.709200E-01
Pancreatitis-vs-NoPancreatitis
9.050000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.989400E-01
Normal-vs-N1
9.501600E-01
N0-vs-N1
8.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.127400E-01
Normal-vs-TP53-NonMutant
8.586200E-01
TP53-Mutant-vs-TP53-NonMutant
1.342640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
